|
PPT1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.00050000009888E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.42959999954928E-07 |
| Normal-vs-Stage2 |
6.570200E-01 |
| Normal-vs-Stage3 |
3.50940000004574E-06 |
| Normal-vs-Stage4 |
1.756290E-04 |
| Stage1-vs-Stage2 |
4.560800E-03 |
| Stage1-vs-Stage3 |
6.577600E-01 |
| Stage1-vs-Stage4 |
7.778200E-01 |
| Stage2-vs-Stage3 |
4.195500E-03 |
| Stage2-vs-Stage4 |
1.124230E-02 |
| Stage3-vs-Stage4 |
9.571800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.54569999711552E-08 |
| Normal-vs-AfricanAmerican |
1.063860E-02 |
| Normal-vs-Asian |
1.66956999999579E-05 |
| Caucasian-vs-AfricanAmerican |
5.399000E-01 |
| Caucasian-vs-Asian |
2.310000E-01 |
| AfricanAmerican-vs-Asian |
8.270200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.477320E-03 |
| Normal-vs-Female |
6.53439999886984E-08 |
| Male-vs-Female |
1.711240E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.06610000014807E-07 |
| Normal-vs-Age(41-60Yrs) |
2.16389999996291E-06 |
| Normal-vs-Age(61-80Yrs) |
4.376600E-03 |
| Normal-vs-Age(81-100Yrs) |
8.901500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.056200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.186800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.954600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.423200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.390600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.439800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.773800E-01 |
| Classical-VS-Follicular |
4.0055736505451E-12 |
| Classical-VS-Other |
1.432960E-01 |
| Classical-VS-Normal |
1.63300484246065E-11 |
| Tall-VS-Follicular |
8.22860000138093E-08 |
| Tall-VS-Other |
9.290000E-02 |
| Tall-VS-Normal |
2.82829999975753E-07 |
| Follicular-VS-Other |
2.574200E-01 |
| Follicular-VS-Normal |
1.520200E-01 |
| Other-VS-Normal |
5.392200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.555900E-03 |
| Normal-vs-N1 |
2.760400E-03 |
| N0-vs-N1 |
4.691400E-01 |
|
|
